News

Three to five years after vaccination, the study found a three-fold increase in typhoid incidence in children who received TCV in 2018/2019 and those who received it in 2021, suggesting a decline ...
Just 24 children who got the vaccine developed typhoid, compared to 110 kids who didn't receive it -- a more than 78% efficacy rate.
A single dose of a typhoid conjugate vaccine provided protection for at least 4 years among children aged 9 months to 12 years enrolled in a phase 3 trial in Malawi, according to results published ...
A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by ...
A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages nine months to 12 years old, according to a new study conducted ...
Typhoid fever, caused by Salmonella typhi bacteria in sewage and contaminated food, infects up to 20 million people a year and kills up to 160,000 of them, mostly young children.
A new vaccine will allow doctors to immunize children younger than 5 against typhoid fever, a disease that affects 16 million people worldwide and kills 600,000 every year.
GlaxoSmithKline's <GSK.N> <GSK.L> Typherix vaccine shields children as young as 2 from typhoid fever, and widespread vaccination can even protect people who have not been given the shot, according ...
The vaccine was given to 10,005 children in Lalitpur, Nepal, where the disease is endemic. Another 10,014 were immunized against meningococcal disease (MenA) to serve as a control group.
The ministry had targeted 19.2 million children for typhoid and 6.5 million for MR vaccines. Notably, some 4,000 zero-dose children—those never previously vaccinated, received both vaccines.
Three to five years after vaccination, the study found a three-fold increase in typhoid incidence in children who received TCV in 2018/2019 and those who received it in 2021, suggesting a decline ...